Takeda M&A hunt, Allergan acquisition send smaller drugmakers higher By: TalkMarkets September 14, 2016 at 15:53 PM EDT Takeda Pharmaceutical, Japan's largest drugmaker, is reportedly setting aside up to $20B as it hunts for acquisitions in the U.S. Read More >> Related Stocks: Acadia Pharmaceutica Adamas Pharma Allergan Plc Astellas Pharma Inc Bluebird Bio Evoke Pharma Exelixis Inc Seagen Inc Synergy Pharma Takeda Pharma Theravance Bio Ord Valeant Pharmaceuticals International, Inc.